A Clinical Trial to study the Effect of Daily Abhyanga with Balaswagandha Lakshadi taila in Response Inhibition among Children with Hyperactivity.

A Randomized Controlled Trial to Evaluate the Effect of Daily Abhyanga with Balaswagandha Lakshadi Taila in Response inhibition Among Children with Hyperactivity. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/060989

Enrollment

Registered

2024-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F988- Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Screened for hyperactivity using Conner Abbreviated Teacher Rating scale and selected subjects who has a score above 15 Consent from Parents / Guardian. Assent.

Exclusion criteria

Exclusion criteria: Children who are under medication for epilepsy. Children who have asthma and experience repeated or frequent episodes of asthma attacks. Children with skin disorders.

Design outcomes

Primary

Measure	Time frame
•Response inhibition.Timepoint: • At baseline, 3 months	—

Secondary

Measure	Time frame
HyperactivityTimepoint: at baseline, 3 months	—

Countries

India

Contacts

Public ContactDr Arathi M Nair

Amrita School of Ayurveda

drvandana@ay.amrita.edu9446441441

Outcome results